Entrectinib in children, adolescents and young adults with extracranial solid or primary CNS tumours harbouring NTRK1/2/3, ROS1, or ALK fusions: Updated data from STARTRK-NG Meeting Abstract


Authors: Desai, A.; Robinson, G.; Basu, E.; Foster, J.; Sabnis, A.; Maese, L.; Yoon, J.; Cash, T.; Pratilas, C.; Wu, Y.; Morgenstern, D.; Van Tilburg, C.; Casanova, M.; Campbell-Hewson, Q.; Verschuur, A.; Marshall, L.; Ku, D. T. L.; Corradini, N.; Wang, H.; Chohan, S.; Cardenas, A.; Hutchinson, K.; Devlin, C.; Wulff, J.; Gajjar, A.; Fox, E.
Abstract Title: Entrectinib in children, adolescents and young adults with extracranial solid or primary CNS tumours harbouring NTRK1/2/3, ROS1, or ALK fusions: Updated data from STARTRK-NG
Meeting Title: 54th Congress of the International Society of Paediatric Oncology (SIOP)
Journal Title: Pediatric Blood and Cancer
Volume: 69
Issue: Suppl. 5
Meeting Dates: 2022 Sep 28-Oct 1
Meeting Location: Barcelona, Spain
ISSN: 1545-5009
Publisher: Wiley Periodicals, Inc  
Date Published: 2022-11-01
Start Page: S314
End Page: S315
Language: English
ACCESSION: WOS:000859203901267
PROVIDER: wos
DOI: 10.1002/pbc.29952
Notes: Meeting Abstract: EP360 / #440 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ellen Marlese Basu
    101 Basu